162 related articles for article (PubMed ID: 34196424)
1. SRSF-1 and microvessel density immunohistochemical analysis by semi-automated tissue microarray in prostate cancer patients with diabetes (DIAMOND study).
Broggi G; Lo Giudice A; Di Mauro M; Asmundo MG; Pricoco E; Piombino E; Caltabiano R; Morgia G; Russo GI
Prostate; 2021 Sep; 81(12):882-892. PubMed ID: 34196424
[TBL] [Abstract][Full Text] [Related]
2. Insulin signaling, androgen receptor and PSMA immunohistochemical analysis by semi-automated tissue microarray in prostate cancer with diabetes (DIAMOND study).
Broggi G; Lo Giudice A; Di Mauro M; Pricoco E; Piombino E; Ferro M; Caltabiano R; Morgia G; Russo GI
Transl Res; 2021 Dec; 238():25-35. PubMed ID: 34314871
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor overexpression in prostate cancer in type 2 diabetes.
Lutz SZ; Hennenlotter J; Scharpf MO; Sailer C; Fritsche L; Schmid V; Kantartzis K; Wagner R; Lehmann R; Berti L; Peter A; Staiger H; Fritsche A; Fend F; Todenhöfer T; Stenzl A; Häring HU; Heni M
Mol Metab; 2018 Feb; 8():158-166. PubMed ID: 29249638
[TBL] [Abstract][Full Text] [Related]
4. High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy.
Li R; Wheeler T; Dai H; Frolov A; Thompson T; Ayala G
Am J Surg Pathol; 2004 Jul; 28(7):928-34. PubMed ID: 15223964
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of microvessel density and proliferation in prostate cancer core biopsy.
Matic SD; Rakocevic MS; Jocic TT; Todorovic MS; Vuckovic LM; Jancic SA; Knezevic MG
J BUON; 2017; 22(3):757-765. PubMed ID: 28730786
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of microvessel density in prostate cancer: a tissue microarray study.
Erbersdobler A; Isbarn H; Dix K; Steiner I; Schlomm T; Mirlacher M; Sauter G; Haese A
World J Urol; 2010 Dec; 28(6):687-92. PubMed ID: 19714336
[TBL] [Abstract][Full Text] [Related]
7. Ki-67 Immunostaining and its Correlation with Microvessel Density in Patients with Mutiple Myeloma.
Himani B; Meera S; Abhimanyu S; Usha R
Asian Pac J Cancer Prev; 2016; 17(5):2559-64. PubMed ID: 27268630
[TBL] [Abstract][Full Text] [Related]
8. Pathological significance and prognostic role of microvessel density, evaluated using CD31, CD34, and CD105 in prostate cancer patients after radical prostatectomy with neoadjuvant therapy.
Miyata Y; Mitsunari K; Asai A; Takehara K; Mochizuki Y; Sakai H
Prostate; 2015 Jan; 75(1):84-91. PubMed ID: 25307287
[TBL] [Abstract][Full Text] [Related]
9. Dermal microvessel density and maturity is closely associated with atherogenic dyslipidemia and accumulation of advanced glycation end products in adult patients with type 1 diabetes.
Adamska A; Araszkiewicz A; Pilacinski S; Gandecka A; Grzelka A; Kowalska K; Malinska A; Nowicki M; Zozulinska-Ziolkiewicz D
Microvasc Res; 2019 Jan; 121():46-51. PubMed ID: 30312628
[TBL] [Abstract][Full Text] [Related]
10. The angiogenic switch for vascular endothelial growth factor-A and cyclooxygenase-2 in prostate carcinoma: correlation with microvessel density, androgen receptor content and Gleason grade.
Gyftopoulos K; Vourda K; Sakellaropoulos G; Perimenis P; Athanasopoulos A; Papadaki E
Urol Int; 2011; 87(4):464-9. PubMed ID: 21912077
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of the impact of ischemic change in benign prostatic hyperplasia.
Jin Cho W; Pyo JS
Pathol Res Pract; 2020 Jan; 216(1):152694. PubMed ID: 31734054
[TBL] [Abstract][Full Text] [Related]
12. Predictive values of vascular endothelial growth factor and microvessel-density levels in initial biopsy for prostate cancer.
Kervancioglu E; Kosan M; Erinanc H; Gonulalan U; Oguzulgen AI; Coskun EZ; Ozkardes H
Kaohsiung J Med Sci; 2016 Feb; 32(2):74-9. PubMed ID: 26944325
[TBL] [Abstract][Full Text] [Related]
13. Pericyte coverage of differentiated vessels inside tumor vasculature is an independent unfavorable prognostic factor for patients with clear cell renal cell carcinoma.
Cao Y; Zhang ZL; Zhou M; Elson P; Rini B; Aydin H; Feenstra K; Tan MH; Berghuis B; Tabbey R; Resau JH; Zhou FJ; Teh BT; Qian CN
Cancer; 2013 Jan; 119(2):313-24. PubMed ID: 22811049
[TBL] [Abstract][Full Text] [Related]
14. Prognostic relevance of proliferation markers (Ki-67, PHH3) within the cross-relation of ERG translocation and androgen receptor expression in prostate cancer.
Goltz D; Montani M; Braun M; Perner S; Wernert N; Jung K; Dietel M; Stephan C; Kristiansen G
Pathology; 2015 Dec; 47(7):629-36. PubMed ID: 26517642
[TBL] [Abstract][Full Text] [Related]
15. Correlation of microvessel density with nuclear pleomorphism, mitotic count and vascular invasion in breast and prostate cancers at preclinical and clinical levels.
Muhammadnejad S; Muhammadnejad A; Haddadi M; Oghabian MA; Mohagheghi MA; Tirgari F; Sadeghi-Fazel F; Amanpour S
Asian Pac J Cancer Prev; 2013; 14(1):63-8. PubMed ID: 23534805
[TBL] [Abstract][Full Text] [Related]
16. Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillance.
Jhavar S; Bartlett J; Kovacs G; Corbishley C; Dearnaley D; Eeles R; Khoo V; Huddart R; Horwich A; Thompson A; Norman A; Brewer D; Cooper CS; Parker C
Prostate Cancer Prostatic Dis; 2009; 12(2):143-7. PubMed ID: 18762814
[TBL] [Abstract][Full Text] [Related]
17. Imaging proliferation of ¹⁸F-FLT PET/CT correlated with the expression of microvessel density of tumour tissue in non-small-cell lung cancer.
Yang W; Zhang Y; Fu Z; Sun X; Mu D; Yu J
Eur J Nucl Med Mol Imaging; 2012 Aug; 39(8):1289-96. PubMed ID: 22581165
[TBL] [Abstract][Full Text] [Related]
18. An analysis of microvessel density, androgen receptor, p53 and HER-2/neu expression and Gleason score in prostate cancer . preliminary results and therapeutic implications.
Mydlo JH; Kral JG; Volpe M; Axotis C; Macchia RJ; Pertschuk LP
Eur Urol; 1998; 34(5):426-32. PubMed ID: 9803006
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of an epithelial plasticity biomarker panel in men with localized prostate cancer.
Armstrong AJ; Healy P; Halabi S; Vollmer R; Lark A; Kemeny G; Ware K; Freedland SJ
Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):40-5. PubMed ID: 26458958
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
Ho PJ; Baxter RC
Clin Endocrinol (Oxf); 1997 Mar; 46(3):333-42. PubMed ID: 9156044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
